Preparation, in vitro characterization and in vivo release of naproxen loaded in poly-caprolactone nanoparticles

References

• American Hospital Formulary Service (AHFS) Drug Information 2006: Central nervous system agents: Nonsteroidal anti-inflammatory agents. Copyright 2006. Bestheda, MD: American Society of Health-System Pharmacist®; 2006:1977–2095.
   Google Scholar
• Hawkey CJ. COX-1 and COX-2 inhibitors. Best Pract Res Clin Gastroenterol. 2001;15(5):801–820.
   PubMed Web of Science ®Google Scholar
• Shenoy DB, Amiji MM. Poly(ethylene oxide)-modified poly(-caprolactone) nanoparticles for targeted delivery of tamoxifen in breast cancer. Int J Pharm. 2005;293:261–270.
   PubMed Web of Science ®Google Scholar
• Bowman D, Hodge GA. Nanotechnology: Mapping the wild regulatory frontier. Future 2006;38:1060–1073.
   Google Scholar
• Soppimath KS, Aaminabhaui TM, Kulkarni AR, Rudzinski WE. Biodegradable polymeric nanoparticle as delivery devices. J Control Rel 2001;70:1–20.
   PubMed Web of Science ®Google Scholar
• Hans ML, Lowman AM. Biodegradable nanoparticles for drug delivery and targeting. Curr Opin Solid STM 2002;6:319–327.
   Web of Science ®Google Scholar
• Pitt CG, Gratzel MM, Kimmel GL, Surles J, Schindler A. Aliphatic polyester. 2. The degradation of poly(D-L-lactide), poly(-caprolactona) and their copolymers in vivo. Biomaterials 1981;2:215–220.
   PubMed Web of Science ®Google Scholar
• Rajeev J, Shah N, Malick AW, Rhodes CT. Controlled drug delivery by biodegradable poly(ester)devices: different preparative approaches. Drug Dev Ind Pharm 1998;24(8):703–727.
   PubMed Web of Science ®Google Scholar
• Yang J, Park SB, Yoon GH, Huh YM, Haam S. Preparation of poly caprolactone nanoparticles containing magnetite for magnetic drug carrier. Int J Pharm 2006;324(2):185–190.
   PubMed Web of Science ®Google Scholar
• Sinha VR, Bansal K, Kaushik R, Kumria R, Trehan A. Poly-caprolactone microspheres and nanospheres: An overview. Int J Pharm 2004;278:1–23.
   PubMed Web of Science ®Google Scholar
• Espuelas MS, Legrand P, Ieache JM, Gamazo C, Orecchioni AM, Devissaguet J-Ph, Ygartua P. Poly(-Caprolactone) nanospheres as an alternative way to reduce amphotericin-B toxicity. Int J Pharm 1997;158:19–27.
   Web of Science ®Google Scholar
• Park S-J, Lee WM, Hong S-K. Release behaviors of porous poly(butylenes succinate)/poly(caprolactone) microcapsules containing indometacin. Colloid Surf B 2006;47:211–215.
   PubMed Web of Science ®Google Scholar
• Zili Z, Sfar S, Fessi H. Preparation and characterization of poly-caprolactone nanoparticles containing griseofulvin. Int J Pharm 2005;294:261–267.
   PubMed Web of Science ®Google Scholar
• Singh J, Pandit S, Bramwell VW, Alpar HO. Diphtheria toxoid loaded poly-(caprolactone) nanoparticles as mucosal vaccine delivery systems. Methods 2006;38:96–105.
   PubMed Web of Science ®Google Scholar
• Yenice I, Mocan MC, Palaska E, Bochot A, Bilensoy E, Vural I, İrkeç M, Hıncal AA. Hyaluronic acid coated poly-3-caprolactone nanospheres deliver high concentrations of cyclosporine A into the cornea. Exp Eye Res 2008;87(3):162–167.
   PubMed Web of Science ®Google Scholar
• Friedrich RB, Fontana MC, Beck RCR, Pohlmann AR, Guterres SS. Development and physicochemical characterization of dexamethasone-loaded polymeric nanocapsules suspension. Quim Nova 2008;31(5):1131–1136.
   Web of Science ®Google Scholar
• Chacon M, Molpeceres J, Berges L, Guzman M, Aberturas MR. Stability and freeze-drying of cyclosporine loaded poly(D,L lactide-glycolide) carriers. Eur J Pharm Sci 1999;8: 99–107.
   PubMed Web of Science ®Google Scholar
• Abdelwahed W, Degobert G, Stainmesse S, Fessi H. Freeze-drying of nanoparticles: Formulation, process and storage considerations. Adv Drug Del Rev. 2006;58:1688–1713.
   PubMed Web of Science ®Google Scholar
• Maestrelli F, Zerrouk N, Chemtob C, Mura P. Influence of chitosan and its glutamate and hydrochloride salts on naproxen dissolution rate and permeation across Caco-2 cells. Int J Pharm 2004;271:257–267.
   PubMed Web of Science ®Google Scholar
• ANVISA resources pages. Agência Nacional de Vigilância Sanitária Web site. http://www.anvisa.gov.br/. Guia para a Realização de Estudos de Estabilidade. (RE- No. 1, July 29, 2005). Accessed November 10, 2008.
   Google Scholar
• Barzegar-Jalali M, Adibkia K, Valizadeh H, Shadbad MRS, Nokhodchi A, Omidi Y, Mohammadi G, Nezhadi SH, Hasan M. Kinetic analysis of drug release from nanoparticles. J Pharm Pharm Sci 2008;11(1):167–177.
   PubMed Web of Science ®Google Scholar
• Costa P, Lobo JMS. Modeling and comparison of dissolution profiles. Eur J Pharm Sci 2001;13:123–133.
   PubMed Web of Science ®Google Scholar
• Tanaka N, Imai K, Okimoto K, Ueda S, Tokunaga Y, Ibuki R, Higaki K, Kimura T. Development of novel sustained-release system, disintegration-controlled matrix tablet (DCMT) with solid dispersion granules of nilvadipine. J Control Rel 2005;108:386–395.
   PubMed Web of Science ®Google Scholar
• Varelas CG, Dixon DG, Steiner C. Zero-order release from biphasic polymer hydrogels. J Control Rel 1995;34:185–192.
   Web of Science ®Google Scholar
• Gibaldi M, Feldman S. Establishment of sink conditions in dissolution rate determinations-theoretical considerations and application to nondisintegrating dosage forms. J Pharm Sci 1967;56(10):1238–1242.
   PubMed Web of Science ®Google Scholar
• Wagner JG. Interpretation of percent dissolved-time plots derived from in vitro testing of conventional tablets and capsules. J Pharm Sci 1969;58(10):1253–1257.
   PubMed Web of Science ®Google Scholar
• Mulye NV, Turco SJ. A simple model based on first order kinetics to explain release of highly water soluble drugs from porous dicalcium phosphate dehydrate matrices. Drug Dev Ind Pharm 1995;21(8):943–953.
   Web of Science ®Google Scholar
• Hixson AW, Crowell JH. Dependence of reaction velocity upon surface and agitation. Ind Eng Chem Res 1931;23:923–931.
   Google Scholar
• Baker RW, Lonsdale HS. Controlled release: mechanism and rates. In:Taquary AC, Lacey RE, editors. Controlled release of biological active agents. New York: Plenum Press; 1974:15–71.
   Google Scholar
• Higuchi T. Mechanism of sustained-action medication: Theoretical analysis of rate of release of solid drug dispersed in solid matrices. J Pharm Sci 1963;52:1145–1149.
   PubMed Web of Science ®Google Scholar
• Moore JW, Flanner HH. Mathematical comparison of dissolution profiles. Pharm Tech 1996; 20:64–74.
   Google Scholar
• Veronese FM, Marsilio F, Caliceti P, De Filippis P, Giunchedi P, Lora S. Polyorganophosphazene microspheres for drug release: Polymer synthesis, microsphere preparation, in vitro and in vivo naproxen release. J Control Rel 1998;52:227–237.
   PubMed Web of Science ®Google Scholar